Jeffrey S. Cole
Chief Operating Officer at Cadrenal Therapeutics.
- Ponte Vedra, FL
- Cadrenal Therapeutics
Raised on Cadrenal Therapeutics filings
$16.8M
of $16.8M offered across 2 Form D filings
- Form D filings
- 2
- Teammates
- 8
- Last filing
- Jul 15, 2026
Company
Cadrenal Therapeutics
Biotech · Ponte Vedra, FL
Drugs for heparin-induced thrombocytopenia and clotting
Drugs for heparin-induced thrombocytopenia and clotting
- Investors
- 1
- Founded
- 2022
Cadrenal Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jul 15, 2026 | Security to be acquired | $8.8M/ $8.8M | Form D |
| Apr 6, 2026 | Security to be acquired | $7.9M/ $7.9M | Form D |
